Imm Cancer Research Results
Imm, immunostimulatory: Click to Expand ⟱
| Source: |
| Type: |
Enhance the immune response in patients.
|
Nor, Normal Healthy: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*Wound Healing↑, *Imm↑, *antiOx↑, *AntiDiabetic↑, *AntiCan↑, *Inflam↓, *NF-kB↓, *COX2↓, *5LO↓, *IL1β↓, *IL6↓, *TNF-α↓, *IL10↑, *other↓, *ROS↓, *SOD↑, *Catalase↑, *GPx↑, *lipid-P↓, *DNAdam↓, *GutMicro↑, *ZO-1↑, AntiTum↑, Casp3↑, Casp9↑, angioG↓, MMPs↓, VEGF↓, NK cell↑,
*eff↑, *IL6↑, *toxicity↓, *Imm↑,
Imm↑, *Dose↝, *BioAv↓, *toxicity↑,
*Dectin1↑, *Imm↑, *TNF-α↓,
*Imm↑, *cardioP↑, *LDL↓, toxicity↓,
*Inflam↓, GutMicro↑, Imm↑,
*Imm↑, *Inflam↓, *Bacteria↓, *eff↑, *ROS↓, *MDA↓, *Catalase↑, *GSH↑, *TAC↑, *NF-kB↓, *NLRP3↓, *eff↑, *AST↓, *ALAT↓, *SOD↑, *GSTA1↑,
*NF-kB↓, *Imm↑, *Inflam↓,
*Inflam↓, *NF-kB↓, *DPPH↓, *TNF-α↓, *Imm↑,
| - |
vitro+vivo, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-453 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
NF-kB↓, AntiTum↑, tumCV↓, TumCP↓, Apoptosis↑, TumCMig↓, TumCI↓, EMT↓, TumCG↓, OS↑, TumMeta↓, CD4+↑, CD8+↑, Imm↑,
*Dose↑, *toxicity↓, *Imm↑,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
*lipid-P↓, *ROS↓, *Inflam↓, *BP↓, *cardioP↑, *chemoPv↑, *BioAv⇅, *antiOx↑, *Risk↓, *5LO↓, *AntiAg↑, *Imm↑, *NF-kB↓, *other↓, CYP1A1↓, COX2↓, *Obesity↓, *cognitive↑,
Showing Research Papers: 1 to 12 of 12
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 12
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
CYP1A1↓, 1,
Cell Death ⓘ
Apoptosis↑, 1, Casp3↑, 1, Casp9↑, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, TumCG↓, 1,
Migration ⓘ
MMPs↓, 1, TumCI↓, 1, TumCMig↓, 1, TumCP↓, 1, TumMeta↓, 1,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1, COX2↓, 1, Imm↑, 3, NF-kB↓, 1, NK cell↑, 1,
Clinical Biomarkers ⓘ
GutMicro↑, 1,
Functional Outcomes ⓘ
AntiTum↑, 2, OS↑, 1, toxicity↓, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 24
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 2, Catalase↑, 2, DPPH↓, 1, GPx↑, 1, GSH↑, 1, GSTA1↑, 1, lipid-P↓, 2, MDA↓, 1, ROS↓, 3, SOD↑, 2, TAC↑, 1,
Core Metabolism/Glycolysis ⓘ
ALAT↓, 1, LDL↓, 1,
Transcription & Epigenetics ⓘ
other↓, 2,
DNA Damage & Repair ⓘ
DNAdam↓, 1,
Migration ⓘ
5LO↓, 2, AntiAg↑, 1, ZO-1↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, Dectin1↑, 1, IL10↑, 1, IL1β↓, 1, IL6↓, 1, IL6↑, 1, Imm↑, 9, Inflam↓, 6, NF-kB↓, 5, TNF-α↓, 3,
Protein Aggregation ⓘ
NLRP3↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv⇅, 1, Dose↑, 1, Dose↝, 1, eff↑, 3,
Clinical Biomarkers ⓘ
ALAT↓, 1, AST↓, 1, BP↓, 1, GutMicro↑, 1, IL6↓, 1, IL6↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiDiabetic↑, 1, cardioP↑, 2, chemoPv↑, 1, cognitive↑, 1, Obesity↓, 1, Risk↓, 1, toxicity↓, 2, toxicity↑, 1, Wound Healing↑, 1,
Infection & Microbiome ⓘ
Bacteria↓, 1, Dectin1↑, 1,
Total Targets: 52
Scientific Paper Hit Count for: Imm, immunostimulatory
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1332 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page